Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Contingent Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹925 Cr₹1,019 Cr₹89 Cr₹48 Cr₹83 Cr

What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?

The latest Contingent Liabilities ratio of MANKIND PHARMA is ₹925 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹925 Cr
Mar2025₹1,019 Cr
Mar2024₹89 Cr
Mar2023₹48 Cr
Mar2022₹83 Cr

How is Contingent Liabilities of MANKIND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2026 ₹925 Cr
-9.29
Mar2025 ₹1,019 Cr
1,045.33
Mar2024 ₹89 Cr
85.77
Mar2023 ₹48 Cr
-41.97
Mar2022 ₹83 Cr -

Compare Contingent Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,352.8 Cr 6.2% 1.9% -10.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,196.0 Cr 1.8% -1.7% 14.6% Stock Analytics
DIVIS LABORATORIES ₹250,390.0 Cr 2.6% 9.8% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,967.0 Cr 2.4% -0.5% 36% Stock Analytics
CIPLA ₹111,888.0 Cr 1.8% -3.7% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,329.0 Cr 4.5% 1.8% -10% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

6.2%

1.9%

-10.3%

SENSEX

0.1%

-2.7%

-8.6%


You may also like the below Video Courses